Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Breast cancer sentinel lymph node metastasis in-vivo fluorescence targeting tracer agent and preparation method thereof

A sentinel lymph node and breast cancer technology, applied in the field of biomedicine, can solve the problems of long time, increased workload of pathologists, and no indication of the presence of metastases, etc.

Pending Publication Date: 2020-10-20
王永胜
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, after research by the inventors, it has been found that the tracers of these detection methods only have the function of locating the sentinel lymph nodes, but do not have the function of indicating whether there are metastases. Increased workload. At the same time, intraoperative rapid frozen pathological examination and postoperative routine pathological diagnosis of sentinel lymph nodes will take a long time, which will affect the surgeon's judgment on the patient's condition

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Breast cancer sentinel lymph node metastasis in-vivo fluorescence targeting tracer agent and preparation method thereof
  • Breast cancer sentinel lymph node metastasis in-vivo fluorescence targeting tracer agent and preparation method thereof
  • Breast cancer sentinel lymph node metastasis in-vivo fluorescence targeting tracer agent and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] (1) Prepare 10 mL of 0.1 mg / mL CK19 monoclonal antibody solution and 10 mL of 2.5 mg / mL Cy754 solution respectively;

[0039](2) Take 10 mg of cross-linking agent 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride EDC, make it with 2.5 ml of 10 mmol / L phosphate buffer solution PBS with pH 8.0 Dissolve fully and prepare liquid I;

[0040] (3) Take 2mL of Cy754 solution and dissolve it in 2mL of 0.2mol / L NaOH solution to prepare II solution;

[0041] (4) Take 5 mL of CK19 monoclonal antibody solution and dissolve it in 2.5 ml of 10 mmol / L phosphate buffered saline buffer solution PBS with pH 8.0 to prepare liquid III;

[0042] (5) Mix liquid II and liquid III, add liquid I dropwise under magnetic stirring, stir at room temperature in the dark for 1 hour, and stir at 4°C for 12 hours, so that the macromolecular CK19 monoclonal antibody and the small molecule Cy754 are fully coupled. Combined reaction, let stand for 10 hours;

[0043] (6) After the coupling rea...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention provides a breast cancer sentinel lymph node metastasis in-vivo fluorescence targeting tracer agent and a preparation method thereof. The targeting tracer agent comprises a cytokeratin 19 monoclonal antibody and Cy754, epsilon-amino of lysine in the cytokeratin 19 monoclonal antibody and carboxyl of the Cy754 form amido bonds to be combined, and one CK19 monoclonal antibody moleculeis connected to 8-12 Cy754 molecules. The preparation method comprises the following steps: adding 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride into a mixed solution of the CK19 monoclonal antibody and Cy754, carrying out a reaction, and carrying out dialysis purification on the material obtained after the reaction to obtain the tracer agent. According to the tracer agent providedby the invention, when the region is detected through the photoacoustic conversion detector, the lymph node subjected to fluorescence targeting development can be found, so that the purpose of determining sentinel lymph node metastasis in vivo is achieved.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and relates to an in vivo fluorescence targeting tracer for breast cancer sentinel lymph node metastasis and a preparation method. Background technique [0002] The information disclosed in this background section is only intended to increase the understanding of the general background of the present invention, and is not necessarily taken as an acknowledgment or any form of suggestion that the information constitutes the prior art already known to those skilled in the art. [0003] The sentinel lymph node is a special lymph node in the lymph nodes of the primary tumor drainage area, and it is the first lymph node that the primary tumor must pass through for lymph node metastasis. The sentinel lymph node of breast cancer is the first lymph node where breast cancer cells metastasize through the lymphatic channel. During the segmental mastectomy plus sentinel lymph node biopsy, a small incision...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K49/00
CPCA61K49/0019A61K49/0058
Inventor 丛斌斌王永胜曹晓珊高永生刘治国李孟柯孙晓邱鹏飞王春建陈鹏张朝鹏吴爽石志强毕钊赵家贤
Owner 王永胜
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products